SKIN CARE EXPERT ADVICE
EXPERT ADVICE
How lockdown is influencing La Roche-Posay’s NPD
Hygiene-conscious consumers require skin care that respects the microbiome, explains Gizela Lascelles
L
’Oréal-owned La Roche-Posay is the best selling dermocosmetic brand in the world, offering a range of daily skin care developed with dermatologists for every skin type. Started from Europe’s leading centre of thermal dermatology, La Roche- Posay develops formulas containing selenium-rich water, otherwise known as Thermal Spring Water, which have been used at the brand’s centre since 1905 thanks to its antioxidant and soothing properties.
Gizela Lascelles is UK Brand Business leader at La Roche-Posay. She tells Cosmetics Business how the coronavirus lockdown has influenced the kinds of products that La Roche- Posay is developing.
How did ‘lockdown culture’ impact La Roche-Posay’s performance? We are seeing that skin care as a category is on the rise; 45% of consumers are spending more time on their routine and being more experimental with products they might not have looked at before. Through the increased levels of knowledge being acquired by our consumers, they understand the ingredients in skin care and are now, more than ever, looking to these when making skin care decisions.
How has the pandemic impacted skin problems?
Living in a pandemic has brought with it a new wave of skin issues that need to be addressed, the most obvious one being ‘maskne’. This is mask wearing- induced acne. We’ve seen a sharp rise in online maskne searches since the beginning of last year and #acnetreatment is up 35%.
Dermatological skin care effectively addresses all skin concerns, including acne in all ages. Effaclar Duo (+) is
cosmeticsbusiness.com
Gizela Lascelles, UK Brand Business leader, La Roche-Posay Gizela Lascelles has worked at La Roche-Posay since 2017 and oversees brand strategy across the UK & Ireland. Previously, she worked across other brands within the L’Oréal group including L’Oréal Paris and Garnier
www.laroche-posay.com
As we are more hygiene-conscious than ever before, ensuring we don’t over-wash and maintain a healthy skin barrier and support the skin microbiome will play an even more important role. We plan to build microbiome science into more of our launches in 2021.
one of our bestsellers and we have seen a sales uplift in the past few months. We’ve also just launched Effaclar Serum, which is specifically developed for adults prone to breakouts with ageing concerns.
Has this influenced the direction of La Roche-Posay’s R&D? La Roche-Posay partners with dermatologists worldwide to develop clinically proven skin care solutions for all skin pathologies, from acne to eczema, and is a pioneer in microbiome science. We know that when the microbiome is compromised this leads to skin pathologies.
As we are more hygiene-conscious than ever before, ensuring we don’t over-wash and support the skin microbiome will play an even more important role
What are the links between skin pathologies and consumers’ emotional and mental health? At La Roche-Posay we understand that skin is more than skin and pathologies can have a profound impact on mental wellbeing. We’re committed to raising awareness of this topic in 2021 and exploring the link between psychological health and skin pathologies.
What else will La Roche-Posay scientists be focusing on in 2021? As above, our focus is on the microbiome specifically around the areas of acne and eczema. We want to deliver a better life for all those people that have sensitive skin – whether it’s acne, eczema or rosacea.
What are your predictions for the skin care market and La Roche-Posay? We have seen an increased importance placed on general health together with a rise in demand for trusted, clinically proven and safe products. This is only set to increase as consumers become more conscious of ingredients and what they’re putting on their skin.
The current climate has meant that more and more shoppers are looking for brands that are trusted, safe and carry medical expertise and endorsement
January 2021 13
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76
